A detailed history of Vanguard Group Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,576,926 shares of ARCT stock, worth $26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,576,926
Previous 1,384,744 13.88%
Holding current value
$26 Million
Previous $33.7 Million 8.55%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.08 - $25.38 $3.47 Million - $4.88 Million
192,182 Added 13.88%
1,576,926 $36.6 Million
Q2 2024

Aug 13, 2024

SELL
$24.35 - $44.39 $76,702 - $139,828
-3,150 Reduced 0.23%
1,384,744 $33.7 Million
Q1 2024

May 10, 2024

SELL
$31.23 - $42.99 $2.2 Million - $3.03 Million
-70,486 Reduced 4.83%
1,387,894 $46.9 Million
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $912,720 - $1.7 Million
51,537 Added 3.66%
1,458,380 $46 Million
Q3 2023

Nov 14, 2023

SELL
$25.44 - $37.35 $5.64 Million - $8.28 Million
-221,573 Reduced 13.61%
1,406,843 $35.9 Million
Q2 2023

Aug 14, 2023

BUY
$23.94 - $32.36 $3.9 Million - $5.28 Million
163,070 Added 11.13%
1,628,416 $46.7 Million
Q1 2023

May 15, 2023

BUY
$14.72 - $23.97 $219,637 - $357,656
14,921 Added 1.03%
1,465,346 $35.1 Million
Q4 2022

Feb 10, 2023

BUY
$14.14 - $23.06 $1.61 Million - $2.62 Million
113,607 Added 8.5%
1,450,425 $24.6 Million
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $1.87 Million - $3.17 Million
143,162 Added 11.99%
1,336,818 $19.8 Million
Q2 2022

Aug 12, 2022

BUY
$12.26 - $31.17 $492,153 - $1.25 Million
40,143 Added 3.48%
1,193,656 $18.8 Million
Q1 2022

May 13, 2022

BUY
$17.64 - $39.57 $110,973 - $248,934
6,291 Added 0.55%
1,153,513 $31.1 Million
Q4 2021

Feb 14, 2022

BUY
$34.2 - $47.56 $1.14 Million - $1.58 Million
33,271 Added 2.99%
1,147,222 $42.5 Million
Q3 2021

Nov 12, 2021

SELL
$27.88 - $58.25 $1.84 Million - $3.84 Million
-65,890 Reduced 5.58%
1,113,951 $53.2 Million
Q2 2021

Aug 13, 2021

BUY
$25.79 - $42.11 $30.4 Million - $49.7 Million
1,179,841 New
1,179,841 $39.9 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.